{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:16:25Z","timestamp":1740179785594,"version":"3.37.3"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T00:00:00Z","timestamp":1636070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007658","name":"Crohn\u2019s and Colitis Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007658","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["VR5 172684"],"award-info":[{"award-number":["VR5 172684"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AbbVie Corporation"},{"DOI":"10.13039\/100016040","name":"Takeda Canada Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The risk of hospitalization and death from Coronavirus disease-19 (COVID-19) increases with age. The extreme elderly have been particularly vulnerable, with those above the age of 80 having a case-fatality rate as high as 15%. Aging of the immune system can lead to impaired inflammatory responses where eradication of an organism such as Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV2) is inadequate but is exaggerated in such a way as to enhance pneumonia and acute respiratory distress syndrome. Frailty and comorbidity are both more common in the elderly, and these can enhance the morbidity and mortality from COVID-19. Studies from Northern California and Italy suggest that elderly persons with inflammatory bowel disease (IBD) were more likely to acquire SARS-CoV-2 infection than youths with IBD. While the specific impact of age-related comorbidity is less well established among people with IBD who acquire COVID-19, data from the Surveillance Epidemiology of Coronavirus Under Research Exclusion (SECURE-IBD) database reported that having two or more chronic illnesses was independently associated with developing severe COVID-19 among people with IBD. Despite having exaggerated auto-inflammatory responses, people with IBD do not appear to have an overall increased risk of developing severe COVID-19 than the general population. However, whether seniors with IBD do worse once they acquire COVID-19 compared with seniors without IBD is not known. The advent of telehealth care has posed an information technology challenge for many seniors with and without IBD. Most persons with IBD have expressed satisfaction with virtual IBD health care (phone or video-based visits). While the elderly may have less robust immune responses to vaccinations, learning from experiences with other vaccination programs, especially influenza, have shown that vaccinating seniors decreases both morbidity and mortality and, in turn, healthcare resources.<\/jats:p>","DOI":"10.1093\/jcag\/gwab025","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T11:51:51Z","timestamp":1625226711000},"page":"S34-S39","source":"Crossref","is-referenced-by-count":2,"title":["Crohn\u2019s and Colitis Canada\u2019s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8041-3574","authenticated-orcid":false,"given":"Charles N","family":"Bernstein","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harminder","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada"},{"name":"IBD Clinical and Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay K","family":"Murthy","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Ottawa Hospital IBD Centre, University of Ottawa, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7083-7429","authenticated-orcid":false,"given":"Geoffrey C","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Mount Sinai Hospital Inflammatory Bowel Disease Centre, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8855-3598","authenticated-orcid":false,"given":"Eric I","family":"Benchimol","sequence":"additional","affiliation":[{"name":"SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Child Health Evaluative Sciences, SickKids Research Institute, Toronto, Ontario, Canada"},{"name":"ICES, Toronto, Ontario, Canada"},{"name":"Department of Paediatrics and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Bitton","sequence":"additional","affiliation":[{"name":"Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3984-8426","authenticated-orcid":false,"given":"M Ellen","family":"Kuenzig","sequence":"additional","affiliation":[{"name":"SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Child Health Evaluative Sciences, SickKids Research Institute, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Guoxian","family":"Huang","sequence":"additional","affiliation":[{"name":"SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Lee","sequence":"additional","affiliation":[{"name":"Crohn\u2019s and Colitis Canada, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura E","family":"Targownik","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7539-9103","authenticated-orcid":false,"given":"Joseph W","family":"Windsor","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam S","family":"Mukhtar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0021-2161","authenticated-orcid":false,"given":"Parul","family":"Tandon","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-0556","authenticated-orcid":false,"given":"Gilaad G","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,11,5]]},"reference":[{"issue":"5","key":"2021110517385968700_CIT0001","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2019.01.002","article-title":"Past and future burden of inflammatory bowel diseases based on modeling of population-based data","volume":"156","author":"Coward","year":"2019","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"2021110517385968700_CIT0002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/jcag\/gwy051","article-title":"The impact of inflammatory bowel disease in Canada 2018: IBD in seniors","volume":"2","author":"Nguyen","year":"2019","journal-title":"J Can Assoc Gastroenterol"},{"issue":"1","key":"2021110517385968700_CIT0003","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"year":"2020","author":"Dutch National Institute for Public Health and the Environment","key":"2021110517385968700_CIT0004"},{"issue":"6","key":"2021110517385968700_CIT0005","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1473-3099(20)30243-7","article-title":"Estimates of the severity of coronavirus disease 2019: A model-based analysis","volume":"20","author":"Verity","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"10229","key":"2021110517385968700_CIT0006","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"2021110517385968700_CIT0007","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/jgs.16472","article-title":"COVID-19 and older adults: What we know","volume":"68","author":"Shahid","year":"2020","journal-title":"J Am Geriatr Soc"},{"issue":"13","key":"2021110517385968700_CIT0008","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"19","key":"2021110517385968700_CIT0009","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.lfs.2005.09.038","article-title":"Age- and gender-related difference of ACE2 expression in rat lung","volume":"78","author":"Xie","year":"2006","journal-title":"Life Sci"},{"key":"2021110517385968700_CIT0010","doi-asserted-by":"crossref","first-page":"6731093","DOI":"10.1155\/2016\/6731093","article-title":"Age-associated changes in the vascular renin-angiotensin system in mice","volume":"2016","author":"Yoon","year":"2016","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"2021110517385968700_CIT0011","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamacardio.2020.1329","article-title":"The dilemma of coronavirus disease 2019, aging, and cardiovascular disease: Insights from Cardiovascular Aging Science","volume":"5","author":"AlGhatrif","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"7","key":"2021110517385968700_CIT0012","doi-asserted-by":"crossref","first-page":"e00127\u201320","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol"},{"key":"2021110517385968700_CIT0013","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/gerona\/glu057","article-title":"Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases","volume":"69 (Suppl 1)","author":"Franceschi","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2021110517385968700_CIT0014","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3389\/fimmu.2017.01960","article-title":"Immunosenescence and inflamm-aging as two sides of the same coin: Friends or foes?","volume":"8","author":"Fulop","year":"2017","journal-title":"Front Immunol"},{"issue":"5","key":"2021110517385968700_CIT0015","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"issue":"10223","key":"2021110517385968700_CIT0016","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"509","key":"2021110517385968700_CIT0017","doi-asserted-by":"crossref","first-page":"eaan2392","DOI":"10.1126\/scisignal.aan2392","article-title":"Aging impairs both primary and secondary RIG-I signaling for interferon induction in human monocytes","volume":"10","author":"Molony","year":"2017","journal-title":"Sci Signal"},{"key":"2021110517385968700_CIT0018","doi-asserted-by":"crossref","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"2021110517385968700_CIT0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.11.024","article-title":"How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity","volume":"83","author":"Smorenberg","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"10229","key":"2021110517385968700_CIT0020","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"2021110517385968700_CIT0021","doi-asserted-by":"crossref","first-page":"E95","DOI":"10.1503\/cmaj.130639","article-title":"Association between frailty and short- and long-term outcomes among critically ill patients: A multicentre prospective cohort study","volume":"186","author":"Bagshaw","year":"2014","journal-title":"CMAJ"},{"issue":"12","key":"2021110517385968700_CIT0022","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00134-017-4940-8","article-title":"The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (\u2265 80 years)","volume":"43","author":"Flaatten","year":"2017","journal-title":"Intensive Care Med"},{"issue":"10132","key":"2021110517385968700_CIT0023","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","article-title":"Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: An observational study","volume":"391","author":"Gilbert","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"2021110517385968700_CIT0024","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/SLA.0000000000003402","article-title":"Frailty in older patients undergoing emergency laparotomy: Results from the UK Observational Emergency Laparotomy and Frailty (ELF) Study","volume":"273","author":"Parmar","year":"2021","journal-title":"Ann Surg"},{"issue":"9","key":"2021110517385968700_CIT0025","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1532-5415.2011.03570.x","article-title":"Interleukin-6, C-reactive protein, and tumor necrosis factor-alpha as predictors of mortality in frail, community-living elderly individuals","volume":"59","author":"Giovannini","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"2021110517385968700_CIT0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2016.08.006","article-title":"Inflammation and frailty in the elderly: A systematic review and meta-analysis","volume":"31","author":"Soysal","year":"2016","journal-title":"Ageing Res Rev"},{"issue":"18","key":"2021110517385968700_CIT0027","first-page":"1775","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","volume":"323","author":"Onder","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"2021110517385968700_CIT0028","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13054-020-2833-7","article-title":"Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan","volume":"24","author":"Shi","year":"2020","journal-title":"Crit Care"},{"issue":"1","key":"2021110517385968700_CIT0029","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCULATIONAHA.120.047659","article-title":"Obesity is a risk factor for severe COVID-19 infection: Multiple potential mechanisms","volume":"142","author":"Sattar","year":"2020","journal-title":"Circulation"},{"issue":"11","key":"2021110517385968700_CIT0030","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"2021110517385968700_CIT0031","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJMra1808137","article-title":"Acute infection and myocardial infarction","volume":"380","author":"Musher","year":"2019","journal-title":"N Engl J Med"},{"issue":"20","key":"2021110517385968700_CIT0032","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"COVID-19 and cardiovascular disease","volume":"141","author":"Clerkin","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"2021110517385968700_CIT0033","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"issue":"10","key":"2021110517385968700_CIT0034","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S2215-0366(20)30287-X","article-title":"Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study","volume":"7","author":"Varatharaj","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"2021110517385968700_CIT0035","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-020-03077-0","article-title":"The unique characteristics of COVID-19 coagulopathy","volume":"24","author":"Iba","year":"2020","journal-title":"Crit Care"},{"key":"2021110517385968700_CIT0036","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"issue":"1","key":"2021110517385968700_CIT0037","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/s13054-020-03260-3","article-title":"Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: A multicentre observational study","volume":"24","author":"Shah","year":"2020","journal-title":"Crit Care"},{"issue":"2","key":"2021110517385968700_CIT0038","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","article-title":"Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: Results from an International Registry","volume":"159","author":"Brenner","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"2021110517385968700_CIT0039","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ueg2.12049","article-title":"Inflammatory bowel disease and risk of severe COVID-19: A nationwide population-based cohort study in Sweden","volume":"9","author":"Ludvigsson","year":"2021","journal-title":"United European Gastroenterol J"},{"issue":"7","key":"2021110517385968700_CIT0040","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/gutjnl-2020-321411","article-title":"Outcomes of COVID-19 in 79 patients with IBD in Italy: An IG-IBD study","volume":"69","author":"Bezzio","year":"2020","journal-title":"Gut"},{"issue":"4","key":"2021110517385968700_CIT0041","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/ecco-jcc\/jjaa215","article-title":"Clinical outcomes of Covid-19 in patients with inflammatory bowel disease: A nationwide cohort study","volume":"15","author":"Derikx","year":"2021","journal-title":"J Crohns Colitis"},{"issue":"12","key":"2021110517385968700_CIT0042","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/17474124.2020.1816822","article-title":"COVID-19 in patients with inflammatory bowel disease","volume":"14","author":"Anikhindi","year":"2020","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"2021110517385968700_CIT0043","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.dld.2020.12.013","article-title":"Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population","volume":"53","author":"Maconi","year":"2021","journal-title":"Dig Liver Dis"},{"issue":"4","key":"2021110517385968700_CIT0044","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1053\/j.gastro.2020.06.003","article-title":"Risk of severe coronavirus disease 2019 in patients with inflammatory bowel disease in the United States: A multicenter research network study","volume":"159","author":"Singh","year":"2020","journal-title":"Gastroenterology"},{"issue":"3","key":"2021110517385968700_CIT0045","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1053\/j.gastro.2020.05.009","article-title":"SARS-CoV-2 testing, prevalence, and predictors of COVID-19 in patients with inflammatory bowel disease in Northern California","volume":"159","author":"Gubatan","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"2021110517385968700_CIT0046","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/MIB.0000000000000747","article-title":"Medication utilization and the impact of continued corticosteroid use on patient-reported outcomes in older patients with inflammatory bowel disease","volume":"22","author":"Geisz","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"2021110517385968700_CIT0047","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/gutjnl-2020-322539","article-title":"Effect of IBD medications on COVID-19 outcomes: Results from an International Registry","volume":"70","author":"Ungaro","year":"2021","journal-title":"Gut"},{"issue":"1","key":"2021110517385968700_CIT0048","doi-asserted-by":"crossref","first-page":":e000541","DOI":"10.1136\/bmjgast-2020-000541","article-title":"Life in lockdown: Experiences of patients with IBD during COVID-19","volume":"7","author":"Harris","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"issue":"1","key":"2021110517385968700_CIT0049","doi-asserted-by":"crossref","first-page":"e000581","DOI":"10.1136\/bmjgast-2020-000581","article-title":"Depression, anxiety and stress among patients with inflammatory bowel disease during the COVID-19 pandemic: Australian national survey","volume":"8","author":"Cheema","year":"2021","journal-title":"BMJ Open Gastroenterol"},{"issue":"5","key":"2021110517385968700_CIT0050","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jgh3.12498","article-title":"Care of inflammatory bowel disease patients during coronavirus disease-19 pandemic using digital health-care technology","volume":"5","author":"Ghoshal","year":"2021","journal-title":"JGH Open"},{"issue":"6","key":"2021110517385968700_CIT0051","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/ibd\/izaa223","article-title":"Innovation in IBD care during the COVID-19 pandemic: Results of a cross-sectional survey on patient-reported experience measures","volume":"27","author":"Taxonera","year":"2021","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"2021110517385968700_CIT0052","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/ije\/22.2.334","article-title":"Impact of influenza on mortality in relation to age and underlying disease, 1967-1989","volume":"22","author":"Sprenger","year":"1993","journal-title":"Int J Epidemiol"},{"key":"2021110517385968700_CIT0053","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.smim.2018.10.010","article-title":"Vaccination in the elderly: The challenge of immune changes with aging","volume":"40","author":"Ciabattini","year":"2018","journal-title":"Semin Immunol"},{"issue":"4","key":"2021110517385968700_CIT0054","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/infdis\/jix282","article-title":"The importance of frailty in the assessment of influenza vaccine effectiveness against influenza-related hospitalization in elderly people","volume":"216","author":"Andrew","year":"2017","journal-title":"J Infect Dis"},{"issue":"4","key":"2021110517385968700_CIT0055","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1086\/422646","article-title":"Detection and control of influenza outbreaks in well-vaccinated nursing home populations","volume":"39","author":"Monto","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2021110517385968700_CIT0056","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/cid\/ciu328","article-title":"Modeling the effect of different vaccine effectiveness estimates on the number of vaccine-prevented influenza-associated hospitalizations in older adults","volume":"59","author":"Fry","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021110517385968700_CIT0057","first-page":"CD004876","article-title":"Vaccines for preventing influenza in the elderly","volume":"2","author":"Demicheli","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"21","key":"2021110517385968700_CIT0058","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"Shapiro","year":"1991","journal-title":"N Engl J Med"},{"key":"2021110517385968700_CIT0059","doi-asserted-by":"crossref","first-page":"n188","DOI":"10.1136\/bmj.n188","article-title":"Vaccines for older adults","volume":"372","author":"Cunningham","year":"2021","journal-title":"BMJ"},{"issue":"4","key":"2021110517385968700_CIT0060","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11938-019-00257-y","article-title":"Vaccination in the elderly and IBD","volume":"17","author":"Choi","year":"2019","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"8","key":"2021110517385968700_CIT0061","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2011.11.109","article-title":"Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review","volume":"30","author":"Agarwal","year":"2012","journal-title":"Vaccine"},{"key":"2021110517385968700_CIT0062","article-title":"Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD","author":"Kennedy","year":"2021","journal-title":"Gut"}],"container-title":["Journal of the Canadian Association of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcag\/article-pdf\/4\/Supplement_2\/S34\/41090853\/gwab025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcag\/article-pdf\/4\/Supplement_2\/S34\/41090853\/gwab025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T17:39:50Z","timestamp":1636133990000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcag\/article\/4\/Supplement_2\/S34\/6421751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,5]]},"references-count":62,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2021,11,5]]},"published-print":{"date-parts":[[2021,11,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jcag\/gwab025","relation":{},"ISSN":["2515-2084","2515-2092"],"issn-type":[{"type":"print","value":"2515-2084"},{"type":"electronic","value":"2515-2092"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,11,5]]}}}